- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05821907
Sexual Health Literacy Scale (SHLS)
Development of the Sexual Health Literacy Scale
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34854
- Marmara University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Individuals over the age of 18 who are willing to participate in the study, without psychiatric illness,
- No physical or mental disability
- Able to speak and understand Turkish.
Exclusion Criteria:
- Not willing to participate in the study, with psychiatric illness,
- Physically and mentally handicapped
- 18 years and under,
- Does not speak Turkish
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
scale development
Time Frame: 3 month
|
The data will be collected with the online data collection tool created by the researchers through the software called google forms. During data collection, the e-mail address of the researchers will be indicated on the form so that the questions of the participants can be answered by the researchers. You will be informed that filling out the data collection form will take an average of 10 minutes for each participant. In addition, in order to evaluate the test-retest reliability of the scale, data collection tools will be sent to at least 30 randomly selected individuals from the sample two weeks after the first data collection. |
3 month
|
|
test-retest reliability of the scale
Time Frame: Retest( later 2 weeks)
|
In order to evaluate the test-retest reliability of the scale, data collection tools will be sent to at least 30 randomly selected individuals from the sample two weeks after the first data collection.
Therefore, after the pre-application, the scale will be applied to 400 people within the scope of the calculated sample, and then, two weeks later, at least 50 people will be re-applied from the individuals to whom the same scale was applied.
|
Retest( later 2 weeks)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Rüveyda ölmez yalazı, PhDc, Marmara University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2023.shls.olmezyalazi
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.